Advanced Inpatient Cancer Treatment

Dr. Edgar Payán leads CMN Hospital’s Advanced Cancer Treatment program, a physician-directed inpatient approach focused on supporting the body’s immune response through carefully coordinated therapies, ongoing medical evaluation, and individualized patient care. Treatments are selected and adjusted throughout the program based on each patient’s diagnosis, condition, and response during care.

Dendritic Cell Therapy

Dendritic cell therapy at CMN Hospital is provided exclusively within Dr. Edgar Payán’s 28-day inpatient cancer treatment program. Unlike simplified self-administered approaches sometimes referred to as “vaccines,” the therapy is performed as a coordinated inpatient treatment process involving multiple treatment sessions, ongoing medical monitoring, and daily physician oversight throughout the patient’s stay.

As part of the process, the patient’s own blood is used for preparation of autologous immune-related cells during treatment sessions throughout the program. Low-dose Filgrastim, a leukocyte growth factor belonging to the colony-stimulating factor class, is used during the preparation process to support immune-related cell stimulation and mobilization.

Because the therapy utilizes the patient’s own immune-related cells, no donor cells are used. Dendritic cells are often referred to as “messenger” cells of the immune system because they help recognize and present tumor-related markers to other immune-related cells as part of the body’s immune response.

Autologous Bone Marrow Stem Cell Therapy

Autologous bone marrow–derived stem cell therapy is performed as a separate procedure within CMN Hospital’s physician-supervised inpatient cancer treatment program. The procedure involves obtaining bone marrow aspirate in an operating room under sedation and medical supervision.

Unlike a routine peripheral blood draw, bone marrow aspiration allows access to bone marrow–derived stem cells, Natural Killer (NK) cells, and additional immune-related cellular components found within the bone marrow environment itself.

Because the stem cells originate from the patient’s own body, no donor cells are used. The bone marrow–derived cells are prepared and incubated prior to reinfusion as part of the individualized treatment process during the patient’s inpatient stay.

How These Therapies Work Together

Within CMN Hospital’s inpatient treatment program, dendritic cell therapy and autologous bone marrow–derived stem cell therapy are coordinated as complementary therapies designed to support the body’s immune response during treatment.

Dendritic cells are often referred to as the “messenger” cells of the immune system because they help recognize and present tumor-related markers to other immune-related cells. Bone marrow–derived cells contain stem cells, Natural Killer (NK) cells, and additional immune-related cellular components associated with immune system activity, cellular communication, and supportive immune response during treatment.

By integrating these therapies together within the inpatient treatment program, Dr. Edgar Payán is able to monitor patient response closely while coordinating individualized therapies and supportive care throughout each patient’s treatment process.

Advanced Supportive Therapies

Intravenous (IV) nutrient therapy is used within CMN Hospital’s physician-directed inpatient program to deliver vitamins, minerals, and additional supportive nutrients directly into the bloodstream under medical supervision.

Additional supportive therapies used within CMN Hospital’s inpatient treatment program may include Intravenous (IV) nutrient therapy, Hyperbaric Oxygen Therapy (HBOT), Ultraviolet Blood Irradiation (UBI), Major Autohemotherapy (MAH) ozone therapy, and additional physician-directed supportive treatments selected based on the patient’s condition and overall treatment plan.

These therapies are coordinated alongside dendritic cell therapy, autologous bone marrow–derived stem cell therapy, and additional inpatient treatments as part of Dr. Edgar Payán’s individualized physician-supervised program. Therapies are adjusted throughout care based on the patient’s response, diagnosis, pathology, imaging, and ongoing medical evaluation during treatment.

Throughout th